Diagnostic approach and differential diagnosis in patients with hypertrophied left ventricles

Heart

Volumn 100, Issue 8, 2014, Pages 662-671

  Yilmaz, Ali ^a   Sechtem, Udo ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATHLETE; CARDIOVASCULAR MAGNETIC RESONANCE; DANON DISEASE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; HEART AMYLOIDOSIS; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BIOPSY; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MITOCHONDRIAL MYOPATHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

AMYLOIDOSIS; CARDIOMEGALY, EXERCISE-INDUCED; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MITOCHONDRIAL MYOPATHIES; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 84897107958     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-301528     Document Type: Article

References (21)

1. Maron MS. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2012;14:13.
2. Yilmaz A, Kindermann I, Kindermann M, et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation 2010;122:900-9.
3. Adabag AS, Maron BJ, Appelbaum E, et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008;51:1369-74. (Pubitemid 351443083)
4. Waterhouse DF, Ismail TF, Prasad SK, et al. Imaging focal and interstitial fibrosis with cardiovascular magnetic resonance in athletes with left ventricular hypertrophy: implications for sporting participation. Br J Sports Med 2012;46(Suppl 1):i69-77.
5. Maron BJ, Pelliccia A, Spirito P. Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation 1995;91:1596-601.
6. Petersen SE, Selvanayagam JB, Francis JM, et al. Differentiation of athlete's heart from pathological forms of cardiac hypertrophy bymeans of geometric indices derived from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2005;7:551-8. (Pubitemid 40770332)
7. Raman SV. The hypertensive heart. An integrated understanding informed by imaging. J Am Coll Cardiol 2010;55:91-6.
8. Yilmaz A, Sechtem U. Angina pectoris in patients with normal coronary angiograms: current pathophysiological concepts and therapeutic options. Heart 2012;98:1020-9.
9. Rudolph AA, Abdel-Aty H, Bohl S, et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 2009;53:284-91.
10. Puntmann VO, Jahnke C, Gebker R, et al. Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy. Am J Cardiol 2010;106:1016-22.
11. Noureldin RA, Liu S, Nacif MS, et al. The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012;14:17.
12. Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011;58:e212-60.
13. Rapezzi C, Merlini G, Quarta CC, et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 2009;120:1203-12.
14. Srinivasan G, Joseph M, Selvanayagam JB. Recent advances in the imaging assessment of infiltrative cardiomyopathies. Heart 2013;99:204-13.
15. Vogelsberg H, Mahrholdt H, Deluigi CC, et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 2008;51:1022-30. (Pubitemid 351318125)
16. Syed IS, Glockner JF, Feng D, et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 2010;3:155-64.
17. Holmgren D, Wahlander H, Eriksson BO, et al. Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings. Eur Heart J 2003;24:280-8. (Pubitemid 36207084)
18. Bates MG, Bourke JP, Giordano C, et al. Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management. Eur Heart J 2012;33:3023-33.
19. Yilmaz A, Gdynia HJ, Ponfick M, et al. Cardiovascular magnetic resonance imaging (CMR) reveals characteristic pattern of myocardial damage in patients with mitochondrial myopathy. Clin Res Cardiol 2012;101:255-61.
20. Braunlin EA, Harmatz PR, Scarpa M, et al. Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management. J Inherit Metab Dis 2011;34:1183-97.
21. Moon JC, Sheppard M, Reed E, et al. The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson 2006;8:479-82.